Cytomegalovirus and burns: Current perceptions, awareness, diagnosis, and management strategies in the United States and Germany

Journal of Burn Care and Research

Volumn 27, Issue 3, 2006, Pages 281-288

  Tenenhaus, Mayer ^a   Rennekampff, Hans Oliver ^a   Pfau, Matthias ^a   Hamprecht, Klaus ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; AWARENESS; BODY FLUID; BURN; COLITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; GERMANY; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; INTERSTITIAL PNEUMONIA; LEUKOCYTE; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENICITY; PERCEPTION; RNA ANALYSIS; SCREENING TEST; SERODIAGNOSIS; UNITED STATES; VIRUS ENCEPHALITIS; VIRUS HEPATITIS; VIRUS ISOLATION;

BURN UNITS; BURNS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DATA COLLECTION; DNA, VIRAL; GERMANY; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; QUESTIONNAIRES; UNITED STATES; VIREMIA;

EID: 33745647510     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/01.BCR.0000216727.89220.24     Document Type: Article

References (41)

1. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001;357:513-8.
2. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7.
3. Proesch S, Doecke WD, Reinke P, Volk HD, Kruege DH. Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes. Intervirology 1999;42:308-13.
4. Doecke WD, Proesch S, Fietze E, et al. Cytomegalovirus reactivation and tumor necrosis factor. Lancet 1994;343:513-8.
5. Munster AM. The immunological response and strategies for intervention. In: Herndon DN, editor. Total Burn Care. London: WB Saunders Company Ltd; 1996. p. 279-92.
6. Antonacci AC, Reaves LE, Calvano SE, Amand R, De Riesthal HF, Shires T. Flow cytometric analysis of lymphocyte subpopulations after thermal injury in human beings. Surg Gynecol Obstet 1984;159:1-8.
7. O'Mahony JB, Wood JJ, Rodrick ML, Mannick JA. Changes in T lymphocyte subsets following injury. Assessment by flow cytometry and relationship to sepsis. Ann Surg 1985;202:580-6.
8. Zedler S, Bone RC, Baue AE, Henkel von Donnersmarck G, Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999;27:66-72.
9. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001;29:541-7.
10. Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998;26:1076-82.
11. Shires GT. Evolution of trauma and trauma research. J Trauma 1991;30:107-15.
12. Huang YS, Li A, Yang ZC. Clinical studies on postburn multiple organ failure: its aetiological factors and monitoring. Burns 1992;18:26-9.
13. Bale JF, Kealey GP, Massanari RM, Strauss RG. The epidemiology of cytomegalovirus infection among patients with burns. Infect Control Hosp Epidemiol 1990;11:17-22.
14. Kealey GP, Bale JF, Strauss RG, Massanari RM. Cytomegalovirus infection in burn patients. J Burn Care Rehabil 1987;8:543-5.
15. Hamprecht K, Pfau M, Schaller HE, Jahn G, Middeldorp JM, Rennekampff HO. Human cytomegalovirus infection in a severe burn patient: evidence for self limited viral replication in blood and lung. J Clin Microbiol 2005;43:2534-6.
16. Linnemann CC, MacMillan BG. Viral infections in pediatric burn patients Am J Dis Child 1981;135:750-3.
17. Grangeot-Keros L, Cointe D. Diagnosis and prognostic markers of HCMV infection. J Clin Virol 2001;21:213-21.
18. Preiser W, Brauninger S, Schwerdtferger R, et al. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol 2001;20:59-70.
19. Hamprecht K, Steinmassl M, Einsele H, Jahn G. Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection. J Clin Virol 1998;11:125-36.
20. Schoppel K, Kropff B, Schmidt C, Vornhagen R, Mach M. The humoral immune response against human cytomegalovirus is characterized by a delayed sythesis of glycoprotein-specific antibodies. J Infect Dis 1997;175:533-44.
21. Greijer AE, Verschuuren EA, Harmsen MC, et al. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification. J Clin Microbiol 2001;39:251-9.
22. Pang XL, Chili L, Fenton J, Leblanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS Amplicor CMV Monitor, and pp65 antigenemia assay for quantitative measurement of cytomegalovirus load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol 2003;41:3167-74.
23. Nash G, Asch MJ, Foley FD, Pruitt BA. Disseminated cytomegalic inclusion disease in a burned adult. JAMA 1970;214:587-8.
24. Seeman J, Konigova R. Cytomegalovirus infections in severely burned patients. Acta Chir Plast 1976;18:142-51.
25. Kealey GP. Disease transmission by means of allograft. J Burn Care Rehabil 1997;18:S10-1.
26. Kagan RJ, Naraqi S, Matsuda T, Jonasson OM. Herpes simplex virus and cytomegalovirus infectious in burned patients. J Trauma 1985;25:40-5.
27. Erickson EJ, Saffle JR, Morris SE, Sullivan JJ, Eichwald EJ, Shelby J. Cytomegalovirus infection promotes bacterial translocation in thermally injured mice. J Burn Care Rehabil 1990;11:428-35.
28. Erickson EJ, Saffle JR, Morris SE, Eichwald EJ, Sullivan JJ, Shelby J. Bacterial translocation is prolonged in burned mice infected with cytomegalovirus. J Burn Care Rehabil 1991;12:454-7.
29. Hamilton JR, Overall JC. Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice. J Infect Dis 1978;137:7775-82.
30. Hamilton JR, Overall JC, Glasgow LA. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun 1976;14:982-9.
31. Kobayashi H, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Susceptibility of thermally injured mice to cytomegalovirus infection. Burns 2001;27:675-80.
32. Adler SP. Transfusion-associated cytomegalovirus infection. J Infect Dis 1983;6:977-93.
33. Pamphilon DH, Rider JR, Barbara JA, Williamson LM. 1999. Prevention of transfusion-transmitted cytomegalovirus infection. Transfus Med 1999;9:115-23.
34. Kealey GP, Aguiar J, Lewis RW II, Rosenquist MD, Strauss RG, Bale JF Jr. Cadaver skin allografts and transmission of human cytomegalovirus to burn patients. J Am Coll Surg 1996;182:201-5.
35. Fiala M, Payne JE, Berne TV, et al. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 1975;132:421-33.
36. Jacobs F, Van de Stadt J, Bourgeois N, et al. Severe infections after liver transplantation. Transplant Proc 1989;21:2271-3.
37. Van Baare J, Buitenwerf J, Hoekstra MJ, du Pont JS. Virucidal effect of glycerol as used in donor skin preservation. Burns 1994;20:S77-80.
38. Kobayashi H, Kobayashi M, McCauley RL, Herndon DN, Pollard RB, Suzuki F. Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury. Clin Immun 1999;92:181-7.
39. Shelby J, Shanley J. Transfer of murine cytomegalovirus by syngeneic skin grafts. Transplantation 1987;4:318-20.
40. Moran KT, Thupari JN, O'Reilly TJ, Munster AM. Effect of immunoglobulin G therapy on serum antibody titers of cytomegalovirus in burn patients. Am J Surg 1998;155:294-7.
41. Munster AM, Moran KT, Thupari J, Allo M, Winchurch RA. Prophylactic intravenous immunoglobulin replacement in high risk burn patients. J Burn Care Rehabil 1987;8:376-80.